Literature DB >> 7198437

[Induction chemotherapy with cis-platinum in head and neck tumors. First clinical and histopathologic findings (author's transl)].

K Böheim, C Böheim, H Rauchegger.   

Abstract

Twenty-one patients with advanced previously untreated squamous cell carcinoma of the oral cavity, oro- and hypopharynx and supraglottic region were treated with combined cis-platinum-methotrexate-bleomycin chemotherapy. Methotrexate (20 mg/m2) was given on day 1, after prehydration cis-diaminodichloroplatinum (60 mg/m2) was given with mannitol diuresis on day 2. From day 3 until day 8 15 mg bleomycin was given daily in a 6-h infusion. Three courses were given every 3 weeks. After clinical evaluation for tumor response all patients were operated and underwent postoperative radiotherapy. After induction chemotherapy eight patients (39%) had a complete, five (24%) a partial (shrinkage of measurable disease more than 50%), and seven (33%) a minor response (more than 25% but less than 50% tumor shrinkage). The neoplasms of the oral cavity and the pharynx responded better than the laryngeal primaries. Exophytic tumors responded better to chemotherapy than the endophytic tumors. Histopathologic examination in serial sections demonstrates in all cases--even after clinically complete response--some small rests of tumor in local fibrotic tissue often underneath a regrown mucosal epithelium.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7198437

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  8 in total

1.  Chemotherapy prior to local therapy in advanced squamous cell carcinoma of the head and neck: Preliminary assessment of an intensive drug regimen.

Authors:  E G Elias; P B Chretien; E Monnard; T Khan; W H Bouchelle; P H Wiernik; S D Lipson; K R Hande; T Zentai
Journal:  Cancer       Date:  1979-03       Impact factor: 6.860

2.  [Current status of chemotherapy in malignant head and neck neoplasms (proceedings)].

Authors:  H R Nitze
Journal:  HNO       Date:  1979-02       Impact factor: 1.284

3.  [Cis-diammino-dichloro-platinum therapy of cancers; phase II therapeutic trial].

Authors:  M Hayat; M Bayssas; G Brulé; P Cappelaere; A Cattan; J Chauvergne; B Clavel; J Gouveia; J Guerrin; E Pommatau; F Muggia; G Mathé
Journal:  Nouv Presse Med       Date:  1979-03-31

4.  [Experiences using combination chemotherapy with cis-platinum, bleomycin and methotrexate in the management of advanced squamous cell carcinomas of the head and neck (author's transl)].

Authors:  V Jahnke
Journal:  HNO       Date:  1980-12       Impact factor: 1.284

5.  Role of chemotherapy in head and neck cancer: systemic use of single agents and combinations in advanced disease.

Authors:  F M Muggia; M Rozencweig; A E Louie
Journal:  Head Neck Surg       Date:  1980 Jan-Feb

6.  Histopathologic findings after cis-platinum bleomycin therapy in advanced previously untreated head and neck carcinoma.

Authors:  S M Shapshay; W K Hong; J S Incze; K Yamaguchi; R Bhutani; C W Vaughan; M S Strong
Journal:  Am J Surg       Date:  1978-10       Impact factor: 2.565

7.  Induction chemotherapy in advanced squamous head and neck carcinoma with high-dose cis-platinum and bleomycin infusion.

Authors:  W K Hong; S M Shapshay; R Bhutani; M L Craft; A Ucmakli; K T Yamaguchi; C W Vaughan; M S Strong
Journal:  Cancer       Date:  1979-07       Impact factor: 6.860

8.  Combination therapy of advanced head and neck cancer: induction of remissions with diamminedichloroplatinum (II), bleomycin and radiation therapy.

Authors:  V L Randolph; A Vallejo; R H Spiro; J Shah; E W Strong; A G Huvos; R E Wittes
Journal:  Cancer       Date:  1978-02       Impact factor: 6.860

  8 in total
  4 in total

1.  The effect of chemotherapy in relation to pathohistological tumour grading in head and neck cancer.

Authors:  K Böheim; H Spoendlin
Journal:  Arch Otorhinolaryngol       Date:  1983

2.  Head and neck squamous carcinomas with exophytic and endophytic type of growth have the same prognosis after surgery and adjuvant radiotherapy.

Authors:  Malgorzata Harasymczuk; William Gooding; Aleksandra Kruk-Zagajewska; Jerzy Wojtowicz; Grzegorz Dworacki; Hanna Tomczak; Witold Szyfter; Theresa L Whiteside
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-08-04       Impact factor: 2.503

3.  The prognostic influence of induction chemotherapy on advanced head and neck carcinoma.

Authors:  H Picker; N Zingerle; K Böheim; A Lochs; H Spoendlin
Journal:  Arch Otorhinolaryngol       Date:  1986

4.  Comparisons of histological features among primary oral squamous cell carcinomas before and after adjuvant chemotherapy and their lymph node metastatic cancer lesions after adjuvant chemotherapy.

Authors:  Feng-Chou Cheng; Ling-Hsia Wang; Yi-Ping Wang; Julia Yu-Fong Chang; Chun-Pin Chiang
Journal:  J Dent Sci       Date:  2021-08-21       Impact factor: 2.080

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.